Literature DB >> 29758284

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model.

Clarisse Ganier1, Matthias Titeux1, Sonia Gaucher2, Juliette Peltzer3, Marc Le Lorc'h4, Jean-Jacques Lataillade3, Akemi Ishida-Yamamoto5, Alain Hovnanian6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29758284     DOI： 10.1016/j.jid.2018.04.028

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

Review 1.  Skin Fragility: Perspectives on Evidence-based Therapies.

Authors:  Leena Bruckner-Tuderman
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

Review 2.  Recent advances in understanding and managing epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Alexander Nyström
Journal:  F1000Res       Date:  2018-07-17

Review 3.  An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases.

Authors:  Yanyun Li; Ziyu Ye; Weiqin Yang; Qunzhou Zhang; Jincheng Zeng
Journal:  Stem Cells Int       Date:  2021-01-05       Impact factor: 5.443

4.  Intravenous allogeneic umbilical cord blood-derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients.

Authors:  Sang Eun Lee; Seung-Ju Lee; Song-Ee Kim; Kinam Kim; Boyoung Cho; Kyounghwan Roh; Soo-Chan Kim
Journal:  JCI Insight       Date:  2021-01-25

5.  Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa.

Authors:  Eijiro Akasaka; Hajime Nakano; Daisuke Sawamura
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.